These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9517950)

  • 1. Antibiotic treatment of experimental pneumonic plague in mice.
    Byrne WR; Welkos SL; Pitt ML; Davis KJ; Brueckner RP; Ezzell JW; Nelson GO; Vaccaro JR; Battersby LC; Friedlander AM
    Antimicrob Agents Chemother; 1998 Mar; 42(3):675-81. PubMed ID: 9517950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial filamentation of Yersinia pestis by beta-lactam antibiotics in experimentally infected mice.
    Davis KJ; Vogel P; Fritz DL; Steele KE; Pitt ML; Welkos SL; Friedlander AM; Byrne WR
    Arch Pathol Lab Med; 1997 Aug; 121(8):865-8. PubMed ID: 9278616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous hypoxia reduces the concentration of streptomycin in the blood.
    Chen L; Gao Z
    BMC Infect Dis; 2018 Mar; 18(1):120. PubMed ID: 29523093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Standardization of conditions for the evaluation of effectiveness of antibacterial drugs in pneumonic plague in sacred baboons].
    Romanov VE; Vasil'ev NT; Shabalin BA; Mironin AV; Paramonov VE
    Antibiot Khimioter; 1995 Jun; 40(6):23-30. PubMed ID: 8593090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of oily chloramphenicol depot injection to treat plague in a murine model.
    Rahalison L; Guiyoule A; Bonacorsi SP; Slacanin I; Chanteau S; Carniel E
    J Antimicrob Chemother; 2000 Apr; 45(4):541-5. PubMed ID: 10747836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of resistance selection and mutant growth fitness on the relative efficacies of streptomycin and levofloxacin for plague therapy.
    Louie A; Deziel MR; Liu W; Drusano GL
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2661-7. PubMed ID: 17517837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cethromycin-mediated protection against the plague pathogen Yersinia pestis in a rat model of infection and comparison with levofloxacin.
    Rosenzweig JA; Brackman SM; Kirtley ML; Sha J; Erova TE; Yeager LA; Peterson JW; Xu ZQ; Chopra AK
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5034-42. PubMed ID: 21859946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levofloxacin cures experimental pneumonic plague in African green monkeys.
    Layton RC; Mega W; McDonald JD; Brasel TL; Barr EB; Gigliotti AP; Koster F
    PLoS Negl Trop Dis; 2011 Feb; 5(2):e959. PubMed ID: 21347450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed pneumonic plague and nosocomial MDR-bacterial infection of lung: a rare case report.
    Andrianaivoarimanana V; Bertherat E; Rajaonarison R; Rakotondramaro T; Rogier C; Rajerison M
    BMC Pulm Med; 2018 May; 18(1):92. PubMed ID: 29843675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with Fluticasone Propionate Increases Antibiotic Efficacy during Treatment of Late-Stage Primary Pneumonic Plague.
    Crane SD; Banerjee SK; Pechous RD
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0127521. PubMed ID: 34780267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 2 antibiotics that inhibit protein synthesis for the treatment of infection with Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague.
    Heine HS; Louie A; Sorgel F; Bassett J; Miller L; Sullivan LJ; Kinzig-Schippers M; Drusano GL
    J Infect Dis; 2007 Sep; 196(5):782-7. PubMed ID: 17674322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the effectiveness of antibacterial substances in treating an experimental form of bubonic plague in monkeys].
    Romanov VE; Evstigneev VI; Vasil'ev NT; Shabalin BA; Paramonov VE
    Antibiot Khimioter; 2001; 46(8):6-8. PubMed ID: 11871319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of imipenem for prophylaxis and therapy of Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague.
    Heine HS; Louie A; Adamovicz JJ; Amemiya K; Fast RL; Miller L; Opal SM; Palardy J; Parejo NA; Sörgel F; Kinzig-Schippers M; Drusano GL
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3276-84. PubMed ID: 24687492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis.
    Wendte JM; Ponnusamy D; Reiber D; Blair JL; Clinkenbeard KD
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3752-7. PubMed ID: 21628541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial.
    Randremanana RV; Raberahona M; Randria MJD; Rajerison M; Andrianaivoarimanana V; Legrand A; Rasoanaivo TF; Randriamparany R; Mayouya-Gamana T; Mangahasimbola R; Bourner J; Salam A; Gillesen A; Edwards T; Schoenhals M; Baril L; Horby P; Olliaro P
    Trials; 2020 Aug; 21(1):722. PubMed ID: 32807214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Braun lipoprotein (Lpp) contributes to virulence of yersiniae: potential role of Lpp in inducing bubonic and pneumonic plague.
    Sha J; Agar SL; Baze WB; Olano JP; Fadl AA; Erova TE; Wang S; Foltz SM; Suarez G; Motin VL; Chauhan S; Klimpel GR; Peterson JW; Chopra AK
    Infect Immun; 2008 Apr; 76(4):1390-409. PubMed ID: 18227160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of plague prophylaxis with streptomycin, tetracycline, and rifampicin in simultaneous immunization of white mice by resistant EV NRIEG strain].
    Ryzhko IV; Tsuraeva RI; Moldavan IA; Shcherbaniuk AI
    Antibiot Khimioter; 2004; 49(1):17-21. PubMed ID: 15164519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania.
    Mwengee W; Butler T; Mgema S; Mhina G; Almasi Y; Bradley C; Formanik JB; Rochester CG
    Clin Infect Dis; 2006 Mar; 42(5):614-21. PubMed ID: 16447105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Heme Oxygenase Expression by Cobalt Protoporphyrin Treatment Prevents Pneumonic Plague Caused by Inhalation of
    Willix JL; Stockton JL; Olson RM; Anderson PE; Anderson DM
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of ciprofloxacin-gentamicin combination therapy in murine bubonic plague.
    Lemaître N; Ricard I; Pradel E; Foligné B; Courcol R; Simonet M; Sebbane F
    PLoS One; 2012; 7(12):e52503. PubMed ID: 23285069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.